Reduction of the risk of breast cancer recurrence
Press release (03/05/2018)
The administration of an anti-inflammatory drug during the ablation of the primary tumour reduces the risk of breast cancer recurrence in overweight or obese patients
3 of May 2018 - Christine Desmedt, researcher at the Jules Bordet Institute, on collaboration with the VUB, the UCL and Elia Biganzoli at Istituto Nazionale dei Tumori and University of Milan, published on 30 April in "The Journal of the…
(read more)